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Programmed cell death (apoptosis) is regulated by the Bcl-2 family of proteins. Although it remains unclear how these family members
control apoptosis, they clearly have the capacity to regulate the permeability of intracellular membranes to ions and proteins. Proapoptotic
members of the Bcl-2 family, especially Bax and Bid, have been extensively analyzed for the ability to form channels in membranes and to
regulate preexisting channels. Anti-apoptotic members of the family tend to have the opposing effects on membrane channel formation. The
molecular mechanisms of the different models for the permeabilization of membranes by the Bcl-2 family members and the regulation of Bcl-
2 family member subcellular localizations are discussed.
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The Bcl-2 protein family members are potent regulators
of apoptosis that can influence the permeability of the outer
mitochondrial membrane [1]. Family members Bax, Bak
and Bok promote apoptosis while Bcl-2, Bcl-xL, Bcl-w and
Mcl-1 inhibit cell death. A third subfamily, called the BH3-
only proteins, are more distantly related and promote
apoptosis, perhaps by regulating the former family mem-
bers. While some members of this family are constitutively
localized on the outer mitochondrial membrane such as Bcl-
2 and Bak, these proteins and other family members have
been found in various other sub-cellular locations including
the endoplasmic reticulum, the cytosol and bound to micro-
tubules. The control over the subcellular localizations of
different members of the Bcl-2 family occurs through
heterodimerization, phosphorylation, proteolysis, or interac-
tion with FKBP38. Regardless of the signaling pathway,
Bcl-2 proteins appear ultimately to act at organelle mem-
branes to tranduce cell survival and cell death signals.
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University, Chicago, IL 60628, USA.proteins and ions is regulated by the Bcl-2 family and may
be the mechanism of apoptosis control. How these family
members control membrane permeability remains contro-
versial and will be the focus of this review. The three
dominant theories for how Bcl-2 family members control
membrane permeability are: (1) they form de novo protein
channels in membranes, (2) they interact with and regulate
pre-existing mitochondrial membrane pores, and (3) they
alter the membrane lipid order to produce lipidic pores.2. Bax activation and translocation
In healthy cells Bax exists as a monomer either in the
cytosol or loosely attached to the outer mitochondrial
membrane. Upon induction of apoptosis, the cytosolic Bax
translocates to mitochondria [2–4] and deeply inserts into
the membrane [5]. Almost simultaneously with transloca-
tion, Bax oligomerizes into large complexes that can be
detected biochemically by gel filtration or by chemical
cross-linking [6,7]. Bax oligomerization is considered cru-
cial for mitochondrial membrane permeabilization [8], at
least for the proteinaceous pore model. The C-terminal
membrane anchor folds into a hydrophobic pocket in the
soluble monomeric form of Bax [9] and presumably
becomes exposed and inserted into the lipid bilayer during
apoptosis [10]. Although the domains of Bax that are
involved in oligomer formation remain unknown, the C-
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of Bax is important for bioactivity [11] and could fit into the
empty hydrophobic pocket of another Bax molecule that
would be revealed when the C-terminal tail disengages the
pocket and inserts into membranes. However, a large
conformational rearrangement of Bax would have to occur
for the BH3 domain to become exposed and accessible to
another Bax molecule’s pocket [9].
Confocal and electron microscopy reveal that Bax forms
large clusters or complexes on the mitochondrial membrane
that probably correspond to the biochemically detectable
oligomers [12–14]. Although these foci are tethered to
mitochondria, the Bax EM immunostaining can stretch
some distance beyond the membrane. The activated Bax
on mitochondria can be distinguished from the cytosolic and
loosely attached Bax by a conformational change in the N-
terminus that exposes the formerly buried 6A7 epitope
comprising amino acids 13 to 19 [10,15,16]. Interestingly,
in addition to the hydrophobic membrane anchor domain at
the C-terminus that is established to be required for mem-
brane docking, the N-terminus may also regulate mitochon-
drial targeting [17]. Thus, four events appear to occur in
rapid succession upon Bax activation to promote apoptosis:
exposure of the N-terminal epitope, mitochondrial translo-
cation, oligomerization, and focal clustering on the mito-
chondrial membrane. These changes all occur prior to
caspase activation downstream of mitochondria and corre-
late with the Bax activity that causes mitochondrial outer
membrane permeabilization.
Further dissection of these steps in Bax activation sug-
gests that Bax 6A7 epitope exposure is an initial, reversible
event that occurs prior to oligomerization [71–73]. Loss of
Myc expression also allows a separation of the Bax trans-
location step from downstream apoptosis events. In a model
where Myc expression is required for apoptosis, the loss of
Myc blocks cytochrome c release and cell death but not the
cytosol to membrane Bax translocation step [8]. Interest-
ingly, the absence of Myc also prevented exposure of the
Bax 6A7 epitope [18]. Similarly, a cytosolic factor called
IODA does not block E1A-induced Bax translocation to
mitochondria but blocks cytochrome c release and apoptosis
[19]. Bap31 is an ER protein that is normally cleaved
following caspase 8 activation [20]. Cells expressing a
noncleavable form of Bap31 are resistant to Fas-mediated
apoptosis although Bax still translocates and inserts into
mitochondrial membranes. However, neither exposure of
the Bax N-terminal epitope, Bax oligomerization nor cyto-
chrome c release occurred [20]. Thus, multiple discrete steps
occur during the Bax activation process. These recent
reports suggest that Bax translocation occurs first, 6A7
epitope exposure occurs next and then, after passing an
irreversible step, Bax oligomerizes and cytochrome c is
released.
Genetically, Bax and Bak partially complement one
another [21]. Unlike Bax, however, Bak constitutively
resides on mitochondria [22]. Like Bax, during apoptosisBak homo-oligomerizes [23,24], forms focal complexes on
mitochondria that colocalize with Bax complexes [12] and
exposes an N-terminal epitope [22]. Interestingly, upon
binding Bid, the N-terminus of Bak becomes exposed prior
to oligomerization [25]. Excess Bcl-2 appears to be able to
bind the N-terminal exposed form of Bak and inhibits Bak
oligomerization and thus inhibits mitochondrial membrane
permeabilization [25]. These results argue against the model
that Bcl-2 sequesters Bid to inhibit Bak oligomerization
[26]. Similarly, E1A19K can bind selectively to a Bid-
activated form of Bax and prevent Bax oligmerization and
subsequent events of apoptosis [27]. Truncated Bid also
homo-oligomerizes during apoptosis [28].3. Bax permeabilization of the outer mitochondrial
membrane
In 1997, two reports showed that Bcl-2 prevents cyto-
chrome c release and apoptosis [29,30] indicating that Bcl-2
maintains the integrity of the mitochondrial outer membrane
integrity to prevent cytochrome c release. Bax, opposing
Bcl-2 bioactivity, was then shown to trigger cytochrome c
release in cells [31]. Confirming this, elegant in vitro
experiments showed that recombinant Bax induces cyto-
chrome c release from isolated mitochondria independently
of the origin of the mitochondria, i.e. mouse liver or cell
lines [32–35]. The in vitro experiments also established that
Bax must be in an oligomerized form to induce mitochon-
drial outer membrane permeabilization [8,16].
Incubation of isolated mitochondria with recombinant
Bax showed that Bax also induces the release of other
mitochondrial apoptogenic factors such as Smac/Diablo
and HtrA2/Omi with the same kinetics as cytochrome c
[36]. Interestingly, it was reported that recombinant Bax
does not induce the release of the ‘‘caspase-independent
mitochondrial cell death effectors’’ AIF and Endonuclease
G [36–38].
Although Bax induces pore formation and cytochrome c
release in many in vitro models, it has been difficult to show
that this occurs in vivo. It has been reported that cytochrome
c release occurs both following Bax translocation [39] and
prior to Bax oligomerization [13] but this has not been
studied in real time with endogenous cytochrome c due to
technical limitations for the assessment of Bax activation
and remains an important issue to establish.4. Bid activation of Bax and Bak
A number of proteins have been reported to bind Bax and
regulate Bax bioactivity. Bid, a BH3-only Bcl-2 family
member, has been shown in several labs to activate Bax
and is thought to promote apoptosis by this mechanism (Fig.
1). In healthy cells Bid is cytosolic. Stimulation of cell death
through the Fas/Fas-L or TNF receptor pathway results in the
Fig. 1. Apoptosis induced by the Fas/CD95 and TNF receptors activates Bid cleavage by caspase 8, Bid and Bax translocation to mitochondria, Bax
conformational changes and oligomerization. Other apoptosis inducers, such as drugs, ultraviolet irradiation, growth factor deprivation and DNA damage,
activate Bax by alternate pathways to translocate to mitochondria and oligomerize. The consequence of either Bax activation process is to release cytochrome c,
Smac/Diablo, HtrA2/Omi, AIF and Endo G from the intermembrane space of mitochondria into the cytosol to activate downstream events in programmed cell
death.
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inducing signaling complex. Caspase 8 is then activated and
has the ability to cleave the amino portion of Bid to produce
truncated or t-Bid [40,41]. This truncated protein can be
further posttranslationally modified by the addition of a
myristyl hydrocarbon chain [42]. This processing may result
in the activation of Bid to interact directly with Bax or Bak.
Although Bax alone can induce cytochrome c release from
isolated mitochondria [32,34], Bid synergises with Bax to
induce mitochondrial permeability [43]. Low concentrations
of t-Bid alone also cause cytochrome c leakage from mito-
chondria isolated from mouse liver deficient in Bax [44].
However, the presence of Bak may account for the activity of
t-Bid to induce cytochrome c release [23]. Bid also induces
Bax N-terminal exposure [16], oligomerization [45] and Bak
oligomerization [23].
In vivo results are similar, Bid induces Bax conforma-
tional change [16] and induces apoptosis in a Bax/Bak
dependent way [21,46]. However, the in vivo results are
inconclusive because many cellular insults induce Bax
activation and it is difficult to know if Bid functions directly
by binding Bax or indirectly by activating apoptosis.
Complicating the interpretation that Bid acts directly onBax is the difficulty in directly demonstrating Bid binding
to Bax [28]. This difficulty has led to the kiss and run
hypothesis [26,45] where Bid is proposed to bind to Bax,
and thereby induce a conformational change to activate Bax
and then cycle off the Bax forming only transitory com-
plexes. The Bid knockout mouse [46] has more minor
developmental defects than the Bax knockout mouse, indi-
cating that other BH3 only proteins can substitute for Bid in
activating the developmental cell death pathways controlled
by Bax.5. Bax may regulate the permeability transition pore via
voltage-dependent anion channel (VDAC) or adenine
nucleotide translocase (ANT)
One hypothesis proposes that permeabilization of the
mitochondrial outer membrane to small proteins occurs
through Bcl-2 family member interaction with the mito-
chondrial permeability transition (MPT) pore. The MPTwas
identified as a process characterized by massive swelling of
the mitochondria, depolarization of the inner mitochondrial
membrane and the uncoupling of oxidative phosphorylation
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thought to be controlled by the permeability transition pore
complex (PTPC). Although the complete molecular com-
position of this pore is still unclear, it does include the
mitochondrial VDAC, the ANT and cyclophyllin D. This
complex opens an ion channel in the inner mitochondrial
membrane in response to calcium overload or oxidative
stress that deflates the proton gradient and allows water to
enter the matrix swelling the mitochondria.
Bax has been shown to induce the MPT in cells upon
induction of apoptosis [48] and Bax has been reported to
induce opening of VDAC in synthetic liposomes [49]. In
addition, cyclosporine A and oligomycin, inhibitors of the
MPT, were able to inhibit Bax-mediated VDAC opening
[35]. Other evidence in support of this model comes from
experiments showing that Bax is inefficient in inducing
cytochrome c release in yeast VDAC-1 knockout cells [49].
It was recently reported that a minor isoform of VDAC,
VDAC2, actually binds to Bak and not Bax. VDAC1 did
not bind Bak. VDAC2 overexpression inhibits apoptosis
and Bak oligomerization and may be one mechanism for the
regulation of Bak activity, coupling the MPT pore to the
Bcl-2 family [50].
The ANT, another candidate member of the PTP com-
plex, is an inner mitochondrial membrane protein responsi-
ble for transporting ATP and ADP across the inner
mitochondrial membrane. The ANT has been implicated
in Bax-mediated apoptosis [51]. By yeast two-hybrid
screening, Bax and Bcl-2 were shown to bind to peptides
of the ANT and drugs that inhibit ANT activity also had an
effect on apoptosis [48].6. De novo Bax protein pores
The first evidence to suggest that Bcl-2 family members
form pores in membranes came from structural data that
showed that the anti-apoptotic Bcl-2 family member, Bcl-
xL, is a highly alpha-helical protein with two central
hydrophobic hairpin helices [52]. The structure is reminis-
cent of the domain of diphtheria toxin that forms pores in
membranes [53]. Bcl-xL [54] and the C-terminally truncated
form of Bax [55, 56] were shown to form pores in planar
lipid bilayers at neutral pH, supporting the idea that pore
formation is an important activity of these Bcl-2 family
members. Bcl-xL can either form pores or inhibit Bax pore
formation depending upon the conformation of the Bcl-xL
or the experimental conditions.7. Sizing the pore
The size and nature of the Bax pores are still a matter of
debate. In experiments using reconstituted liposomes Saito
et al. [57] found that C-terminally truncated Bax could form
pores large enough to release cytochrome c and that thesepores were either dimers or tetramers of Bax in dioleoyl-
phosphatidic acid:dioleoylphosphatidyl-choline liposomes.
Bax pores have been visualized in lipid bilayers, appearing
as protein lined channels of different sizes depending on the
bilayer lipid composition and requiring the presence of
calcium [58]. Bax pores in dioleoylphosphatidylserine:dio-
leoylphosphatidylcholine LUV are predicted to have an
inner diameter of f 20 nm and an oligomer number of
22 monomers [58]. Pavlov et al. [59] found by patch
clamping of mitochondrial outer membranes pores of 4-
nm diameter specifically in the presence of Bax. Kuwana et
al. [43] showed that oligomerized Bax combined with a
protease cleaved form of Bid forms very large pores that can
release 2000-kDa size dextran molecules in the absence of
membrane rupture. These megachannels were inhibited by
Bcl-xL and occurred in vesicles derived from mitochondrial
outer membranes.8. Lipidic pores
Bax was also reported to form pores in planar lipid
bilayer experiments that were unstable and resulted in
membrane rupture [60]. The Bax antagonist Bcl-xL was
able to form pores in these experiments, but these pores
were stable and did not result in membrane rupture, indi-
cating that the two proteins functioned differently. These
data suggested the hypothesis that Bax forms lipidic pores.
In this model Bax interacts specifically with lipids inducing
a deformation of the bilayer structure and the formation of
channels that contain both lipids and proteins. In support of
this proposal, Basanez et al. [61] demonstrated that pore
formation by Bax was more efficient in lipids with large
head groups relative to hydrophobic acyl chains that induce
a net positive (convex) curvature to membranes. In contrast,
Bcl-xL prefers to make channels in lipids that induce a net
negative curvature to membranes. In this model, Bcl-xL
could inhibit Bax activity by altering the local curvature of
the lipid resulting in decreased pore formation by Bax.
However, in these experiments Bcl-xL was unable to inhibit
pore formation by Bax [60,61]. Curiously, the truncated
form of Bid has the opposite membrane curvature prefer-
ence of Bax and was more efficient in permeabilizing
liposomes containing lipids with relatively small head
groups relative to the acyl groups that induce a net negative
(concave) curvature to membranes [62]. Truncated Bid also
promotes lipid transfer processes [62,63] and has the ability
to destabilize planar lipid membranes. These results suggest
an alternative model for the activity of Bid to activate Bax
discussed previously. Bid activates Bax to permeabilize the
outer mitochondrial membrane in vitro [16] but it is difficult
to capture Bid–Bax complexes [28] and Bid does not
colocalize with Bax in foci on mitochondria [12]. Alterna-
tive to the kiss and run hypothesis [45], Bid could alter the
composition or curvature of the mitochondrial lipid bilayer
to induce Bax to bind, intercalate and permeabilize the
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critical for Bax membrane pore formation [43]. As Bid
interacts specifically with cardiolipin-containing membranes
[64] and Bid can cause membrane lipid redistribution [65],
cardiolipin redistribution induced by Bid could activate Bax.
In these models no direct interaction between Bid and Bax
need occur.9. Bax inhibitors
Ku70 is a DNA repair enzyme found in the cytosol and
nucleus but not associated with mitochondria. Ku70 was
identified as a Bax binding protein using yeast to screen
mammalian libraries for proteins that would inhibit the
toxicity of Bax overexpressed in yeast [66]. Full-length
Ku70 or the C-terminal 113 amino acids of Ku70 sup-
pressed apoptosis in mammalian cells induced by Bax
overexpression, staurosporine, and UV light. Elimination
of Ku70 increased sensitivity to apoptosis. Ku70 was found
by co-immunoprecipitation experiments to bind to the
cytosolic form of Bax in HEK293T cells and the majority
of the Bax was reported to co-immunoprecipite with Ku70
in the presence of the detergent CHAPS. The authors
suggest that Ku70 binds to Bax and retains it in an inactive
conformation in the cytosol to inhibit apoptosis [66]. This is
somewhat surprising as most of the Bax in the cytosol of
healthy thymocytes [15] and HeLa cells (unpublished)
migrate on gel filtration as a 21-kDa monomer and thus
could not be bound to the 70-kDa version of Ku. Ku70
overexpression blocks Bax translocation but it is very
difficult to know that this is not an indirect effect due to
Ku70 inhibition of apoptosis. Similarly, inhibition of 6A7
antibody binding to Bax by Ku70 could result indirectly due
to the inhibition of apoptosis by Ku70 instead of from a
direct effect of Ku70 on the conformation of Bax. Ku70
clearly plays an interesting role in apoptosis independently
of its DNA repair activity although it remains to be
confirmed that this is due to direct Ku70 sequestration of
Bax.
14-3-3 was also reported recently to bind and sequester
Bax in the cytosol [67]. Using protein cross-linkers and co-
immunoprecipitation, several isoforms of 14-3-3 can be
found bound to Bax. However, the majority of the Bax
from the cytosolic fraction of cells migrates at 21 kDa on gel
filtration columns and thus is not tightly bound to the
monomeric (28–33 kDa) or dimeric (56–66 kDa) forms
of 14-3-3 nor can the bulk of the Bax be bound to both 14-3-
3 and Ku70 simultaneously. Interestingly, the 14-3-3 Bax
binding occurs independently of Bax phosphorylation, in
contrast to the well-established Bad/14-3-3 interaction.
Humanin was recently found to bind to Bax and inhibit
Bax activation [68]. Using a mutant form of Bax constitu-
tively localized in the cytosol as bait in a yeast two-hybrid
screen, Guo and colleagues identified the humanin peptide
as a new Bax binding partner. This peptide binds to thecytosolic form of Bax and is thought to protect cells from
apoptosis by inhibition of Bax activation and translocation
to mitochondria. Interestingly, a second, virtual humanin
peptide is encoded in the mitochondrial genome that, if
expressed, could bind to Bax and inhibit apoptosis. It will be
important to see if and where the mitochondrial encoded
version of humanin is expressed in cells. In contrast to Ku70
and 14-3-3, the molecular weight of Humanin–Bax com-
plexes in the cytosol is not inconsistent with the gel
filtration molecular weight of cytosolic Bax.10. Mitochondrial permeability in Drosophila
The dominant model today for the mechanism of Bax is
that it permeabilizes the outer mitochondrial membrane
allowing proteins in the intermembrane space such as
cytochrome c, HtrA2/Omi and Smac/DIABLO to modulate
downstream steps in apoptosis [69]. However, recent results
show that cells from Drosophila melanogaster [70] undergo
apoptosis without the release of cytochrome c from mito-
chondria. As these organisms express bona fide members of
the Bcl-2 family, it seems plausible that Bcl-2 family
members may also work independently of outer mitochon-
drial membrane permeabilization to control cell viability.References
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